KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $30.8 million.

  • Amneal Pharmaceuticals' Change in Inventory fell 2851.87% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.8 million, marking a year-over-year increase of 1691.94%. This contributed to the annual value of $130.5 million for FY2024, which is 344.58% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Change in Inventory stood at $30.8 million for Q3 2025, which was down 2851.87% from $22.8 million recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Change in Inventory registered a high of $52.0 million during Q4 2024, and its lowest value of -$16.6 million during Q4 2021.
  • Moreover, its 5-year median value for Change in Inventory was $23.2 million (2024), whereas its average is $25.0 million.
  • Data for Amneal Pharmaceuticals' Change in Inventory shows a peak YoY increase of 63012.96% (in 2021) and a maximum YoY decrease of 15029.64% (in 2021) over the last 5 years.
  • Amneal Pharmaceuticals' Change in Inventory (Quarter) stood at -$16.6 million in 2021, then skyrocketed by 166.57% to $11.1 million in 2022, then soared by 108.58% to $23.1 million in 2023, then skyrocketed by 125.14% to $52.0 million in 2024, then tumbled by 40.74% to $30.8 million in 2025.
  • Its Change in Inventory stands at $30.8 million for Q3 2025, versus $22.8 million for Q2 2025 and $13.3 million for Q1 2025.